La fotobiomodulazione acuta può migliorare l'equilibrio e la cognizione negli individui con atassia: uno studio pilota di fattibilità controllato randomizzato con placebo.
La fotobiomodulazione acuta può migliorare l'equilibrio e la cognizione in individui con atassia: uno studio pilota di fattibilità controllato randomizzato con placebo.
Cerebellar ataxias cause progressive impairments in balance, gait coordination, motor timing, and cognitive functions such as attention and executive control (Buckner, 2013; Salmi et al., 2010; Timmann & Daum, 2007). These symptoms substantially reduce independence and quality of life, and current treatments remain limited. There is an urgent need for safe, low-burden interventions that can support everyday functioning and potentially enhance compensatory neural processes.
Transcranial photobiomodulation (tPBM) uses red and near-infrared light (600-1100 nm) to modulate mitochondrial cytochrome-c oxidase, increasing ATP production, reducing oxidative stress, and improving cerebral blood flow (Hamblin, 2016; Salehpour et al., 2019). Several studies show that tPBM can acutely improve cognitive performance and motor control in both healthy adults and clinical groups (Barrett & Gonzalez-Lima, 2013; Chan et al., 2019; Henderson & Morries, 2017). A growing neurobiological literature suggests that light can penetrate posterior cortical areas sufficiently to modulate networks involving cerebellar-cortical loops (Jagdeo et al., 2012).
Importantly for ataxia, preliminary work shows that tPBM may acutely improve balance stability and gait metrics in older adults and patients with neurological conditions (Moro et al., 2022; Shin et al., 2021). In our own laboratory, we have observed immediate improvements in sway range and cognitive control in older adults after a 24-minute tPBM session applied over midline and posterior scalp regions. These medium to large size effects are consistent with enhanced sensorimotor integration and improved control of attention in distracting environments.
Given that individuals with cerebellar ataxia experience both motor incoordination and difficulties in maintaining cognitive stability under distracting conditions, tPBM is a promising non-pharmacological intervention worth preliminary investigation.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Jonathan J Sinclair, DSc
- Numero di telefono: +44787565153
- Email: jksinclair@lancashire.ac.uk
Luoghi di studio
-
-
Lancashire
-
Preston, Lancashire, Regno Unito, PR1 2HE
- University of Central Lancashire
-
Contatto:
- Sinclair
- Numero di telefono: 07875651533
- Email: jksinclair@lancashire.ac.uk
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age 18-70 years (inclusive)
- Diagnosis of ataxia
- Able to walk independently for at least 5 minutes, with or without an assistive device
- Able to stand safely for balance testing, with or without an assistive device
- Hemodynamically stable (stable blood pressure and heart rate at rest)
- On a stable medication regimen for ≥4 weeks prior to enrolment
- Sufficient vision and hearing (with usual aids if required) to complete balance and cognitive assessments
- Able to complete study questionnaires and cognitive tasks (with assistance for reading/writing if required)
- Able and willing to provide written informed consent
Exclusion Criteria:
- Current or past history of head injury
- Use of medications acting on the central nervous system
- Active skin conditions on the forehead or scalp
- Any other major neurological disorder that could independently affect balance or cognition
- Ongoing brain stimulation therapy
- History of migraines
- Sensitive skin, allergies
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Comparatore placebo: Sham Comparator: Sham photobiomodulation
Sham photobiomodulation. The sham device will follow the same protocol but without active light emission. |
The sham device will follow the same protocol but without active light emission. |
|
Sperimentale: Photobiomodulation
Acute photobiomodulation Twenty-four-minute photobiomodulation stimulation (twelve minutes at 670 nm followed by twelve minutes at 810 nm). |
Photobiomodulation |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
n-1-back (deviation)
Lasso di tempo: Baseline
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier. |
Baseline
|
|
n-1-back (deviation)
Lasso di tempo: 1 hour
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier. |
1 hour
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
n-2-back (deviation)
Lasso di tempo: Baseline
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier. |
Baseline
|
|
n-2-back (deviation)
Lasso di tempo: 1 hour
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier. |
1 hour
|
|
n-1-back (post-deviation)
Lasso di tempo: Baseline
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier. |
Baseline
|
|
n-1-back (post-deviation)
Lasso di tempo: 1 hour
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier. |
1 hour
|
|
n-2-back (post-deviation)
Lasso di tempo: Baseline
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier. |
Baseline
|
|
n-2-back (post-deviation)
Lasso di tempo: 1 hour
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier. |
1 hour
|
|
n-1-back (post-target)
Lasso di tempo: Baseline
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier. |
Baseline
|
|
n-1-back (post-target)
Lasso di tempo: 1 hour
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier. |
1 hour
|
|
n-2-back (post-target)
Lasso di tempo: Baseline
|
The n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier. |
Baseline
|
|
n-2-back (post-target)
Lasso di tempo: 1 hour
|
The n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier. |
1 hour
|
|
n-1-back (load)
Lasso di tempo: Baseline
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back. |
Baseline
|
|
n-1-back (load)
Lasso di tempo: 1 hour
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back. |
1 hour
|
|
n-2-back (post-load)
Lasso di tempo: Baseline
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task. |
Baseline
|
|
n-2-back (post-load)
Lasso di tempo: 1 hour
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task. |
1 hour
|
|
Coop-Wonka chart
Lasso di tempo: Baseline
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing. |
Baseline
|
|
Coop-Wonka chart
Lasso di tempo: 1 hour
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing. |
1 hour
|
|
Beck Depression Inventory
Lasso di tempo: Baseline
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible. |
Baseline
|
|
Beck Depression Inventory
Lasso di tempo: 1 hour
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible. |
1 hour
|
|
Pittsburgh Sleep Quality Index
Lasso di tempo: Baseline
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality. |
Baseline
|
|
Pittsburgh Sleep Quality Index
Lasso di tempo: 1 hour
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality. |
1 hour
|
|
State Trait Anxiety Inventory
Lasso di tempo: Baseline
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety. |
Baseline
|
|
State Trait Anxiety Inventory
Lasso di tempo: 1 hour
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety. |
1 hour
|
|
Insomnia Severity Index
Lasso di tempo: Baseline
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28. |
Baseline
|
|
Insomnia Severity Index
Lasso di tempo: 1 hour
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28. |
1 hour
|
|
Epworth Sleepiness Scale
Lasso di tempo: Baseline
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24. |
Baseline
|
|
Epworth Sleepiness Scale
Lasso di tempo: 1 hour
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24. |
1 hour
|
|
Everyday Memory Errors Questionnaire
Lasso di tempo: Baseline
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties. |
Baseline
|
|
Everyday Memory Errors Questionnaire
Lasso di tempo: 1 hour
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties. |
1 hour
|
|
Falls Efficacy
Lasso di tempo: Baseline
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy. |
Baseline
|
|
Falls Efficacy
Lasso di tempo: 1 hour
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy. |
1 hour
|
|
Anterior-posterior balance
Lasso di tempo: Baseline
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task. |
Baseline
|
|
Anterior-posterior balance
Lasso di tempo: 1 hour
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task. |
1 hour
|
|
Medio-lateral balance
Lasso di tempo: Baseline
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task. |
Baseline
|
|
Medio-lateral balance
Lasso di tempo: 1 hour
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task. |
1 hour
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- PMB Ataxia pilot feasibility s
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .